Top

Published in:

01-01-2012 | Letters

Tb in a Global Health Exchange Program

Authors: Matthew DeCamp, MD, PhD, John A. Crump, MB, ChB, DTM&H, Joce Rodriguez, Gene Richardson, MD, Michele Barry, MD FACP, Jeremy Sugarman, MD, MPH, MA

Published in: Journal of General Internal Medicine | Issue 1/2012

Excerpt

To the Editor:— A series of publications in JGIM have begun to examine the personal health risks encountered in global health training programs, including tuberculin skin test (TST) conversion and blood and body fluid exposure1‐3. Clearly, global health training programs abroad harbor risks for trainees. This can be due to disease prevalence (e.g., multi-drug-resistant tuberculosis), the availability of personal protective equipment, and/or the extent to which trainees are prepared, among other factors. …

Gardner A, Cohen A, Carter EJ. Tuberculosis among participants in an academic global health medical exchange program. J Gen Intern Med 2011; 26(8):841–5.PubMedCrossRef

Dandu M. Trainee safety in global health. J Gen Intern Med 2011; 26(8):826–7.PubMedCrossRef

JS, Morrison G, Gluckman S, Lipschik G, Linkin DR, Lyon S, O'Grady E, Calvert H, Friedman H. Medical students in developing countries. J Gen Intern Med 2011; 26(8):833.PubMedCrossRef

Cooke M. Medical students in developing countries: some benefits for sure but a mixture of risks. J Gen Intern Med 2011; 26(5):462–3.PubMedCrossRef

Crump JA, Sugarman J. Working Group on Ethics Guidelines for Global Health Training (WEIGHT). Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg 2010; 83(6):1178–82.PubMedCrossRef

Title: Tb in a Global Health Exchange Program
Authors: Matthew DeCamp, MD, PhD
John A. Crump, MB, ChB, DTM&H
Joce Rodriguez
Gene Richardson, MD
Michele Barry, MD FACP
Jeremy Sugarman, MD, MPH, MA
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: Journal of General Internal Medicine / Issue 1/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-011-1908-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Mentorship, Productivity, and Promotion Among Academic Hospitalists

Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States

Worklife and Satisfaction of Hospitalists: Toward Flourishing Careers

The Impact of Postgraduate Training on USMLE® Step 3® and its Computer-Based Case Simulation Component

Dermatologic Manifestations as Indicators of Immune Status in HIV/AIDS

Provider Characteristics, Clinical-Work Processes and Their Relationship to Discharge Summary Quality for Sub-Acute Care Patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials